ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementTolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal BlockageUpdate on CD40 and CD154 blockade in transplant modelsNonhuman primate models of type 1 diabetes mellitus for islet transplantation.Multipotent mesenchymal stromal cells synergize with costimulation blockade in the inhibition of immune responses and the induction of Foxp3+ regulatory T cells.Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patientsWhat's new in clinical solid organ transplantation by 2013.Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsA circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantationIn vitro testing of an anti-CD40 monoclonal antibody, clone 2C10, in primates and pigs.Costimulation Blockade in Kidney Transplantation: An UpdateImpact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Old game, new players: Linking classical theories to new trends in transplant immunology.Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys.Minimizing immunosuppression in islet xenotransplantation.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotraThe state of the art of islet transplantation and cell therapy in type 1 diabetes.Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects.Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets.
P2860
Q26769878-700522A3-0E63-4D0E-AAD1-1EDE07A5E797Q26778646-8B66EED8-5A71-424C-9E16-AC4B1BBFE83EQ26798362-2AC3F5B4-EE50-49BF-A8BF-CA6019769938Q34441658-3EC1CBE4-E5A8-4309-AD24-93FA40C76D52Q34601883-9CEEFEF8-1FCE-48C3-B7B1-131619C6E260Q34639457-881CA57A-9132-46B9-A071-AF2A76C9A605Q34761349-56A481E4-895E-4E62-A567-0C52398396B0Q35202459-2FFEF10C-7F24-4800-AF77-4B9CE639E1EBQ35379384-89BA635D-C0CE-47BE-988C-38C6BFB35510Q36289120-993123D0-078B-46D5-A51A-DE9684C35A09Q37375148-DC03AAB5-4692-4DEB-BC16-C00F814B0880Q37660263-914A3E01-C11D-44B2-824B-E4F879C24528Q37662989-25018E46-FA36-43E2-92D0-F5AB4ABB3546Q37692472-EF83D08E-2878-4BE9-8EBA-ECB59C489319Q38210810-CC18A778-5346-480C-B049-20372FE94E64Q38346930-7AEEE38A-587A-4335-932A-358103CAE3BAQ38445344-086E5E94-6E9D-4486-AA54-90FFCC7FFD80Q38751293-4C3BE88E-E7CC-44CB-B80E-69CBE5AA775FQ38753743-760A5AEB-70F8-4FCE-93FA-1C465E666356Q39279968-424C77C8-4576-4A6D-8F03-7BDDE528F868Q41824131-6A67CB29-BC85-41DC-A150-429543CE6F26Q50614844-F6AF035C-025A-4AAB-AD8C-5DC9D71798F4Q51585419-816C1D1C-BB52-444D-94DE-D8DCF8D12347Q53211248-789EEF86-4B52-4E79-84BA-E9B18BE09D85
P2860
ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@en
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@nl
type
label
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@en
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@nl
prefLabel
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@en
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@nl
P2093
P2860
P356
P1476
ASKP1240, a fully human anti-C ...... survival in nonhuman primates.
@en
P2093
D Fukumori
K Yamashita
M Watanabe
P2860
P304
P356
10.1111/AJT.12330
P407
P577
2013-07-10T00:00:00Z